Moreover, co-treatment of siRNA for PARP1 and doxorubicin stimulated apoptotic signaling of osteosarcoma cells as indicated by an increase of cleaved PARP1 and BAX and a decrease of BCL2 expression (Fig. 8b). This evidence concerns the gene PARP1 and osteosarcoma.